1. Home
  2. HUT vs ASND Comparison

HUT vs ASND Comparison

Compare HUT & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hut 8 Corp.

HUT

Hut 8 Corp.

HOLD

Current Price

$120.67

Market Cap

14.1B

Sector

Finance

ML Signal

HOLD

Logo Ascendis Pharma A/S

ASND

Ascendis Pharma A/S

HOLD

Current Price

$259.21

Market Cap

15.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HUT
ASND
Founded
2011
2006
Country
United States
Denmark
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.1B
15.2B
IPO Year
2023
2014

Fundamental Metrics

Financial Performance
Metric
HUT
ASND
Price
$120.67
$259.21
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
15
16
Target Price
$65.20
$281.50
AVG Volume (30 Days)
3.7M
671.6K
Earning Date
05-06-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$235,118,000.00
N/A
Revenue This Year
$161.69
$96.35
Revenue Next Year
N/A
$44.91
P/E Ratio
N/A
N/A
Revenue Growth
44.79
N/A
52 Week Low
$17.87
$161.09
52 Week High
$140.80
$271.89

Technical Indicators

Market Signals
Indicator
HUT
ASND
Relative Strength Index (RSI) 56.44 68.16
Support Level $39.84 $213.28
Resistance Level $140.80 N/A
Average True Range (ATR) 10.50 11.32
MACD -1.43 4.80
Stochastic Oscillator 65.55 79.96

Price Performance

Historical Comparison
HUT
ASND

About HUT Hut 8 Corp.

Hut 8 Corp is an energy infrastructure platform that integrates power, digital infrastructure, and compute at scale to fuel next-generation, energy-intensive use cases. The company has four reportable business segments: Power, Digital Infrastructure, Compute, and Other. It derives maximum revenue from the Compute segment which consists of Bitcoin Mining, GPU-as-a-Service, and Data Center Cloud operations. Its geographical segments include the United States and Canada, of which it generates the majority of revenue from the United States.

About ASND Ascendis Pharma A/S

Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.

Share on Social Networks: